Sec Form 4 Filing - Hance Robert B @ ABBOTT LABORATORIES - 2012-02-29

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Hance Robert B
2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Senior Vice President
(Last) (First) (Middle)
100 ABBOTT PARK ROAD
3. Date of Earliest Transaction (MM/DD/YY)
02/29/2012
(Street)
ABBOTT PARK, IL60064-6400
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common shares without par value 02/29/2012 M 46,400 A $ 46.34 199,096 D
Common shares without par value 02/29/2012 M 57,000 A $ 44.16 256,096 D
Common shares without par value 02/29/2012 M 26,000 A $ 48.76 282,096 D
Common shares without par value 02/29/2012 M 47,547 A $ 51.91 329,643 D
Common shares without par value 02/29/2012 M 3,050 A $ 33.2314 332,693 D
Common shares without par value 02/29/2012 F 1,776 D $ 57.04 330,917 D
Common shares without par value 02/29/2012 F 10,133 D $ 57.04 320,784 D
Common shares without par value 02/29/2012 S 6,300 D $ 56.7 314,484 D
Common shares without par value 02/29/2012 S 373 D $ 56.7025 314,111 D
Common shares without par value 02/29/2012 S 18,100 D $ 56.705 296,011 D
Common shares without par value 02/29/2012 S 100 D $ 56.709 295,911 D
Common shares without par value 02/29/2012 S 5,873 D $ 56.71 290,038 D
Common shares without par value 02/29/2012 S 227 D $ 56.7125 289,811 D
Common shares without par value 02/29/2012 S 400 D $ 56.715 289,411 D
Common shares without par value 02/29/2012 S 4,112 D $ 56.72 285,299 D
Common shares without par value 02/29/2012 S 900 D $ 56.725 284,399 D
Common shares without par value 02/29/2012 S 6,550 D $ 56.73 277,849 D
Common shares without par value 02/29/2012 S 8,600 D $ 56.735 269,249 D
Common shares without par value 02/29/2012 S 7,450 D $ 56.74 261,799 D
Common shares without par value 02/29/2012 S 7,627 D $ 56.745 254,172 D
Common shares without par value 02/29/2012 S 400 D $ 56.749 253,772 D
Common shares without par value 02/29/2012 S 6,500 D $ 56.75 247,272 D
Common shares without par value 02/29/2012 S 100 D $ 56.7525 247,172 D
Common shares without par value 02/29/2012 S 200 D $ 56.755 246,972 D
Common shares without par value 02/29/2012 S 6,176 D $ 56.76 240,796 D
Common shares without par value 02/29/2012 S 5,100 D $ 56.765 235,696 D
Common shares without par value 02/29/2012 S 9,900 D $ 56.77 225,796 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy) ( 1 ) $ 46.34 02/29/2012 M 46,400 02/18/2008 02/17/2015 Common shares 46,400 $ 0 0 D
Option (right to buy) ( 1 ) $ 44.16 02/29/2012 M 57,000 02/17/2009 02/16/2016 Common shares 57,000 $ 0 0 D
Option (right to buy) ( 1 ) $ 48.76 02/29/2012 M 26,000 12/29/2009 12/28/2016 Common shares 26,000 $ 0 0 D
Option (right to buy) ( 1 ) $ 51.91 02/29/2012 M 47,547 03/05/2008 02/13/2013 Common shares 47,547 $ 0 0 D
Option (right to buy) ( 2 ) $ 33.2314 02/29/2012 M 3,050 02/14/2006 02/13/2013 Common shares 3,050 $ 0 0 D
Option (right to buy) ( 2 ) $ 57.04 02/29/2012 A 1,776 08/30/2012 02/13/2013 Common shares 1,776 $ 0 1,776 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Hance Robert B
100 ABBOTT PARK ROAD
ABBOTT PARK, IL60064-6400
Senior Vice President
Signatures
John A. Berry, by power of attorney for Robert B. Hance 03/02/2012
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3.
( 2 )Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Remarks:
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 1 of 2.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.